Microsoft is raising prices on Xbox. By a lot. In an announcement today, the company said it will be raising prices on Xbox consoles, controllers, headsets, and some games. The price hike for ...

therapies after its drug candidate pimicotinib cleared a phase 3 trial. The German group said the CSF-1R inhibitor given as a once-daily, oral dose hit its primary endpoint in the MANEUVER study ...

My career has taken me through an eclectic assortment of fields, and connected me with people from all walks of life. This experience includes construction, professional cooking, podcasting, and ...

Matt is currently Head of the Coverage Team at The Motley Fool. He has been a full-time Motley Fool employee since 2012 and is a former advisor and analyst for multiple Motley Fool services.

the company’s pivotal Phase 3 trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer, met its primary endpoint of improved progression-free survival ...